Tuesday, May 22, 2012
  Submit
Videos > Video Player

 

Health Videos

 

 

Average Rating:
Share Video
Rate Now:
Already rated
Flag as Inappropriate
Views:0  |  Rating:0  |  Comments:0
post to:
 Bebo del.icio.us Digg Facebook Live Spaces MySpace StumbleUpon
  Comments & Response
  Post Your Comment
Name: (required)
Email: (required, hidden)
Comment:
Security code:
CAPTCHA image
Enter the code shown above in the box below
OurHealthMinistry Sr. Editor
August 24, 2009
Subscribe
Early Communication on Adverse Events from Botox and Myobloc
FDA has issued an early communication about serious adverse events, including respiratory failure and death, from Botox and Botox Cosmetic (Botulinum toxin Type A), and Myobloc (Botulinum toxin Type B). These events were related to how the product was used, and not to a defect in the manufacturing process. The events occurred one day to several weeks after treatment, and from a wide range of dosages. In the affected patients, the botulinum toxin may have spread beyond the injection site and caused symptoms associated with botulism, including dysphagia and respiratory insufficiency. The most...
Category: Health Safety Tags: * FDA adverse Botox Myobloc cosmetic wrinkles botulinum toxin reaction botulism cerebral palsy CP     
Url:
Embed:

Search Videos

Keyword:
Category:
  Related videos
  More from this author